跳至主要内容
临床试验/NCT01274494
NCT01274494已完成不适用

COMPLIANCE An Observational Study of Treatment Compliance and Quality of Life in Patients on Antihypertensive Medication

AstraZeneca0 个研究点目标入组 1,501 人开始时间: 2011年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
AstraZeneca
入组人数
1,501
主要终点
Compliance rate

研究概览

简要总结

The aim of this multi-centre survey is to assess treatment adherence and quality of life in a Jordanian and Lebanese population newly diagnosed with hypertension or with uncontrolled essential hypertension being on antihypertensive treatment for at least 6 months.

研究设计

研究类型
Observational
时间视角
Prospective

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients older than 21 years of age
  • Patients newly diagnosis with essential hypertension or with hypertension that is uncontrolled after being under the same antihypertensive treatment for at least 6 months (based on the criteria established by the Joint National Committee VII)
  • Patients capable of providing an informed consent

排除标准

  • Patients with secondary hypertension
  • Pregnant women or nursing mothers
  • Patients with acute illnesses or psychiatric diagnosis

结局指标

主要结局

Compliance rate

时间窗: 6 months

Identify the percentage of subjects compliant to their antihypertensive treatment.

次要结局

  • Health Related Quality of Life (MINICHAL Score)(6 months)
  • Compliance rate by antihypertensive regimen used(6 months)
  • Type of pharmacological treatments(6 months)
  • Factors affecting adherence to treatment(6 months)
  • Percentage of controlled patients(6 months)

研究者

发起方
AstraZeneca
申办方类型
Industry
责任方
Sponsor

相似试验